Cellectis S.A. Files 6-K for Board Change
Ticker: CLLS · Form: 6-K · Filed: May 21, 2025 · CIK: 1627281
Sentiment: neutral
Topics: board-change, filing-update, regulatory
TL;DR
Cellectis filed a 6-K for a board change, info incorporated into F-3/S-8 filings.
AI Summary
Cellectis S.A. announced a board change on May 21, 2025. The information regarding this change is incorporated by reference into several of their existing registration statements on Form F-3 and Form S-8.
Why It Matters
Board changes can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of a board change and incorporation of information into existing filings, with no immediate financial or operational impact disclosed.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- May 21, 2025 (date) — Date of Report
- Form 6-K (document) — Filing Type
- Form F-3 (document) — Incorporated Registration Statement
- Form S-8 (document) — Incorporated Registration Statement
FAQ
What specific board change is Cellectis S.A. reporting in this 6-K?
The filing states that information under the caption '—Board Change' is included, but the specific details of the change are not provided in the excerpt.
Which registration statements will incorporate the information from this 6-K?
The information will be incorporated into Cellectis S.A.'s registration statements on Form F-3 (No. 333-265826 and 333-284302) and Form S-8 (Nos. 333-204205, 333-214884, 333-222482, 333-227717, 333-258514, 333-267760, 333-273777 and 333-284301).
What is the filing date of this Form 6-K?
The filing date is May 21, 2025.
What is the principal executive office address for Cellectis S.A.?
The principal executive office is located at 8, rue de la Croix Jarry, 75013 Paris, France.
Does Cellectis S.A. file annual reports under Form 20-F or Form 40-F?
Cellectis S.A. indicates that it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 21, 2025 regarding Cellectis S.A. (CLLS).